Marc Galanter, M.D.
Professor of Psychiatry, Department of Psychiatry; Director
of the Division of Alcoholism and Drug Abuse, New York
University School of Medicine, New York, New York
Herbert D. Kleber, M.D.
Professor of Psychiatry and Director, Division of Substance
Abuse, Columbia University, New York, New York
Sudie E. Back, Ph.D.
Assistanct Professor, Division of Clinical Neuroscience,
Medical University of South Carolina, Charleston, South
Carolina
Monica Barros, M.D.
Chief Resident, Department of Psychiatry, Georgetown University
Hospital, Washington, DC
Steven L. Batki, M.D.
Department of Psychiatry, University of California, San
Francisco; Director, Addiction Psychiatry Research Program,
San Francisco VA Medical Center, San Francisco, California
Adam Bisaga, M.D.
Associate Professor of Clinical Psychiatry, Department of
Psychiatry, Columbia University College of Physicians and
Surgeons; Research Psychiatrist, New York State Psychiatric
Institute, New York, New York
J. Wesley Boyd, M.D., Ph.D.
Associate Director, Physician Health Services, Massachusetts
Medical Society; Assistant Clinical Professor of Psychiatry,
Harvard Medical School; Staff Psychiatrist, Cambridge
Health Alliance, Cambridge, Massachusetts
Kathleen T. Brady, M.D., Ph.D.
Professor of Psychiatry, Division of Clinical Neuroscience,
Medical University of South Carolina, Charleston, South
Carolina
David W. Brook, M.D.
Professor of Psychiatry, New York University School of Medicine,
New York, New York
Judith S. Brook, Ed.D.
Professor of Psychiatry, New York University School of Medicine,
New York, New York
Kirk J. Brower, M.D.
Associate Professor of Psychiatry, Department of Psychiatry;
Executive Director, University of Michigan Addiction Treatment
Services, University of Michigan, Ann Arbor, Michigan
Robert Paul Cabaj, M.D.
Director, San Francisco Department of Public Health Community
Behavioral Health Services; Associate Clinical Professor
in Psychiatry, University of California, San Francisco,
San Francisco, California
Kathleen M. Carroll, Ph.D.
Professor of Psychiatry, Division of Substance Abuse, Yale
University School of Medicine, West Haven, Connecticut
Crystal A. Caudill, M.P.H.
Director, Wedco District Health Department, Cynthiana,
Kentucky
Harvey L. Causey III, M.D.
Medical Director, Morris Village Alcohol and Drug Addiction
Treatment Center, South Carolina Department of Mental
Health; Clinical Assistant Professor of Psychiatry,
Department of Neuropsychiatry, University of South Carolina
School of Medicine, Columbia, South Carolina
Domenic A. Ciraulo, M.D.
Professor and Chairman, Department of Psychiatry, Boston
University School of Medicine, Boston, Massachusetts
Richard R. Clayton, Ph.D.
Associate Dean for Research, College of Public Health, University
of Kentucky, Lexington, Kentucky
Wilson M. Compton, M.D., M.P.E.
Director, Division of Epidemiology, Services, and Prevention
Research, National Institute on Drug Abuse, Bethesda,
Maryland
Gerard J. Connors, Ph.D.
Director, Research Institute on Addictions, University at
Buffalo, Buffalo, New York
George De Leon, Ph.D.
Senior Scientist, Center for Therapeutic Community Research,
National Development and Research Institutes Inc.;
Clinical Professor of Psychiatry, New York University School
of Medicine, New York, New York
Richard Denisco, M.D., M.P.H.
Medical Officer, Division of Epidemiology, Services and
Prevention Research, National Institute on Drug Abuse, Bethesda,
Maryland
Daniel Dickerson, D.O., M.P.H.
Associate Physician, University of California, Los Angeles;
Addiction Psychiatrist, United American Indian Involvement,
Inc., Los Angeles, California
Carlo C. DiClemente, Ph.D. A.B.P.P.
Professor of Psychology, University of Maryland, Baltimore
County, Baltimore, Maryland
Robert L. DuPont, M.D.
President, Institute for Behavior and Health, Inc., Rockville,
Maryland
Nady el-Guebaly, M.D., D.Psych., D.P.H.
Professor and Head, Division of Addiction Psychiatry, Department
of Psychiatry, University of Calgary; Medical Director,
Addictions Program and Centre, Calgary Health
Region, Calgary, Canada
William Fals-Stewart, Ph.D.
Professor of Psychology, University of Rochester School of
Medicine, Rochester, New York
Loretta P. Finnegan, M.D.
President, Finnegan Consulting, LLC., Avalon, New Jersey;
Medical Advisor for the Director (Retired), Office of Research
on Women's Health, National Institutes of Health,
Bethesda, Maryland
Richard J. Frances, M.D.
Director of Professional and Public Education, Silver Hill
Hospital, New Canaan, Connecticut; Clinical Professor of
Psychiatry, New York University, New York, New York; Adjunct
Professor of Psychiatry, University of Medicine and
Dentistry of New Jersey, Newark, New Jersey
Marc Galanter, M.D.
Professor of Psychiatry, Department of Psychiatry; Director
of the Division of Alcoholism and Drug Abuse, New York
University School of Medicine, New York, New York
Miranda Garay, B.A.
Psychology Department, University of Maryland, Baltimore
County, Baltimore, Maryland
Tracie J. Gardner, Ph.D.
Menninger Department of Psychiatry and Behavioral Sciences,
Baylor College of Medicine, Michael E. DeBakey VA
Medical Center, Houston, Texas
David R. Gastfriend, M.D.
Associate Professor of Psychiatry, Harvard Medical School,
Boston, Massachusetts
Joel Gelernter, M.D.
Professor of Psychiatry, Genetics, and Neurobiology, Yale
University School of Medicine; VA Connecticut Healthcare
Center, West Haven, Connecticut
Leigh Gemmell, Ph.D.
Health Services Research and Development Postdoctoral
Fellow, Center for Health Equity Research and Promotion,
VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
Tony P. George, M.D., F.R.C.P.C.
Professor of Psychiatry and Psychology, University Chair in
Addiction Psychiatry, Department of Psychiatry; Head, Addiction
Psychiatry Program, University of Toronto, Centre
for Addiction and Mental Health, Toronto, Ontario
Richard A. Glennon, Ph.D.
Professor and Chair, Department of Medicinal Chemistry,
Virginia Commonwealth University, Richmond, Virginia
Shelly F. Greenfield, M.D., M.P.H.
Associate Professor of Psychiatry, Harvard Medical School,
Boston, Massachusetts; Associate Clinical Director, Alcohol
and Drug Abuse Treatment Program, McLean Hospital, Belmont,
Massachusetts
Erik W. Gunderson, M.D.
Medical Director, Buprenorphine Program and Assistant
Professor of Clinical Medicine (in Psychiatry); Columbia
University College of Physicians and Surgeons and New
York State Psychiatric Institute, New York, New York
Margaret Haney, Ph.D.
Department of Psychiatry, College of Physicians and Surgeons
of Columbia University; Division on Substance
Abuse, New York State Psychiatric Institute, New York, New
York
Grace Hennessy, M.D.
Director, Substance Abuse Recovery Program, VA New York
Harbor Healthcare System, New York, New York
Stephen T. Higgins, Ph.D.
Professor, Departments of Psychiatry and Psychology, University
of Vermont, Burlington, Vermont
Rocco A. Iannucci, M.D.
Medical Director, McGee Unit of the Berkshire Recovery
Center; Psychiatrist, The Brien Center for Mental Health
and Substance Abuse Services, Berkshire Health Systems,
Pittsfield, Massachusetts
Yifrah Kaminer, M.D.
Professor of Psychiatry and Co-Director of Research, Division
of Child and Adolescent Psychiatry, University of Connecticut
Health Center, Farmington, Connecticut
Kyle M. Kampman, M.D.
Assistant Professor, Department of Psychiatry, University of
Pennsylvania, Philadelphia, Pennsylvania
Stephen R. Kandall, M.D.
Professor of Pediatrics (Retired), Albert Einstein College of
Medicine, Bronx, New York
Herbert D. Kleber, M.D.
Professor of Psychiatry and Director, Division of Substance
Abuse, Columbia University, New York, New York
Clifford M. Knapp, Ph.D.
Associate Professor, Department of Psychiatry, Boston University
School of Medicine, Boston, Massachusetts
John R. Knight, M.D.
Associate Director, Physician Health Services, Massachusetts
Medical Society; Associate Professor of Pediatrics, Harvard
Medical School; Director, Center for Adolescent
Substance Abuse Research, Children's Hospital Boston, Boston,
Massachusetts
George F. Koob, Ph.D.
Committee on the Neurobiology of Addictive Disorders,
The Scripps Research Institute, La Jolla, California
Thomas R. Kosten, M.D.
Jay H. Waggoner Chair and Professor of Psychiatry and
Neuroscience, Menninger Department of Psychiatry and
Behavioral Sciences, Baylor College of Medicine; Michael E.
DeBakey VA Medical Center, Houston, Texas
Henry R. Kranzler, M.D.
Professor of Psychiatry and Associate Scientific Director, Alcohol
Research Center, University of Connecticut School of
Medicine, Farmington, Connecticut
Mary Jeanne Kreek, M.D.
Patrick E. and Beatrice M. Haggerty Professor, Head of the
Laboratory of the Biology of Addictive Diseases, The Rockefeller
University, New York, New York
Frances R. Levin, M.D.
Kennedy-Leavy Professor of Clinical Psychiatry, Columbia
University College of Physicians and Surgeons and New
York State Psychiatric Institute, New York, New York
Petros Levounis, M.D.
Director, The Addiction Institute of New York; Chief, Division
of Addiction Psychiatry, and Assistant Professor of
Clinical Psychiatry, Columbia University College of Physicians
and Surgeons, New York, New York
Hallie A. Lightdale, M.D.
Assistant Professor of Clinical Psychiatry, Georgetown University
School of Medicine, Washington, DC
Walter Ling, M.D.
Professor-in-Residence and Director, Integrated Substance
Abuse Programs, Los Angeles, California
Michelle R. Lofwall, M.D.
Assistant Professor, Department of Psychiatry, University of
Kentucky College of Medicine, Lexington, Kentucky
A. Thomas McLellan, Ph.D.
Chief Executive Officer, Treatment Research Institute; Professor
in Psychiatry, University of Pennsylvania School of
Medicine, Philadelphia, Pennsylvania
Avram H. Mack, M.D.
Assistant Professor of Clinical Psychiatry, Georgetown University
School of Medicine, Washington, DC
David Mee-Lee, M.D.
Chief Editor, American Society of Addiction Medicine Patient
Placement Criteria, Second Edition-Revised; DML
Training and Consulting, Davis, California
Rudolf H. Moos, Ph.D.
Senior Research Career Scientist, Center for Health Care
Evaluation and Department of VA Health Care System,
Menlo Park, California; Professor, Stanford University, Palo
Alto, California
Hugh Myrick, M.D.
Associate Professor of Psychiatry, Medical University of
South Carolina and Ralph H. Johnson VA Medical Center,
Charleston, South Carolina
Edgar P. Nace, M.D.
Clinical Professor of Psychiatry, University of Texas Southwestern
Medical School; Medical Director, Turtle Creek
Manor, Dallas, Texas
Kalpana I. Nathan, M.D.
Medical Director, New Horizons, Department of Psychiatry,
Palo Alto VA Health Care System, Menlo Park, California
Charles O'Brien, M.D., Ph.D.
Kenneth E. Appel Professor and Vice-Chair of Psychiatry,
University of Pennsylvania and Philadelphia VA Medical
Center, Philadelphia, Pennsylvania
Timothy J. O'Farrell, Ph.D.
Professor of Psychology, Families and Addiction Program,
Department of Psychiatry, Harvard Medical School; VA
Boston Healthcare System, Brockton, Massachusetts
Kerstin Pahl, Ph.D.
Assistant Professor of Psychiatry, New York University
School of Medicine, New York, New York
Soteri Polydorou, M.D.
Postdoctoral Fellow, Division of Substance Abuse; Assistant
in Clinical Medicine, Columbia University College of Physicians
and Surgeons and New York States Psychiatric Institute,
New York, New York
Harrison G. Pope Jr., M.D.
Professor of Psychiatry, Harvard Medical School, Boston,
Massachusetts; Director, Biological Psychiatry Laboratory,
McLean Hospital, Belmont, Massachusetts
Jennifer Sharpe Potter, Ph.D., M.P.H.
Instructor in Psychology, Department of Psychiatry, Harvard
Medical School, Boston, Massachusetts; Research Director,
Alcohol and Drug Abuse Treatment Program,
McLean Hospital, Belmont, Massachusetts
Richard A. Rawson, Ph.D.
Professor-in-Residence and Associate Director, Integrated
Substance Abuse Programs, Los Angeles, California
Richard K. Ries, M.D.
Professor and Director of Addictions Division, Department
of Psychiatry and Behavioral Sciences, University of Washington
School of Medicine, Seattle, Washington
Jonathan I. Ritvo, M.D.
Medical Director, Center for Dependency Addiction and
Rehabilitation (CeDAR), University of Colorado Hospital;
Clinical Professor of Psychiatry, University of Colorado
School of Medicine, Aurora, Colorado
Stephen Ross, M.D.
Assistant Professor of Psychiatry, Department of Psychiatry;
Associate Director for Addiction Education, New York University
School of Medicine; Director, Division of Alcoholism
and Drug Abuse, Bellevue Hospital, New York, New York
Elizabeth Rubenstone, B.A.
Assistant Research Scientist, New York University School of
Medicine, New York, New York
Sidney H. Schnoll, M.D., Ph.D.
Clinical Professor of Internal Medicine and Psychiatry, Virginia
Commonwealth University, Richmond, Virginia
Richard S. Schottenfeld, M.D.
Professor of Psychiatry, Department of Psychiatry, Yale University
School of Medicine, New Haven, Connecticut
Melissa J.H. Segress, M.S.
Managing Director, Training Resource Center, University of
Kentucky College of Social Work, Lexington, Kentucky
Carl M. Selavka, Ph.D.
Forensic Analytical Chemist, Northeastern Bioscience Associates,
LLC., Charlton, Massachusetts
Kenneth Silverman, Ph.D.
Professor, Department of Psychiatry and Behavioral Sciences,
Johns Hopkins University School of Medicine, Baltimore,
Maryland
Mehmet Sofuoglu, M.D., Ph.D.
Department of Psychiatry, Yale University School of Medicine,
West Haven, Connecticut
Eric C. Strain, M.D.
Professor, Department of Psychiatry and Behavioral Sciences,
Johns Hopkins University School of Medicine, Baltimore,
Maryland
Christine Timko, Ph.D.
Research Career Scientist, Center for Health Care Evaluation
and Department of VA Health Care System, Menlo Park,
California; Consulting Professor, Stanford University, Palo
Alto, California
J. Scott Tonigan, Ph.D.
Associate Research Professor, Department of Psychology,
University of New Mexico, Albuquerque, New Mexico
Michael F. Weaver, M.D.
Associate Professor of Internal Medicine and Psychiatry,
Virginia Commonwealth University, Richmond, Virginia
Andrea H. Weinberger, Ph.D.
Associate Research Scientist, Division of Substance Abuse,
Department of Psychiatry, Yale University School of Medicine,
New Haven, Connecticut
Roger D. Weiss, M.D.
Professor of Psychiatry, Harvard Medical School, Boston,
Massachusetts; Clinical Director, Alcohol and Drug Abuse
Treatment Program, McLean Hospital, Belmont, Massachusetts
Joseph Westermeyer, M.D., Ph.D.
Professor of Psychiatry, University of Minnesota, St. Paul,
Minnesota
Tara Wright, M.D.
Assistant Professor of Psychiatry, Medical University of
South Carolina and Ralph H. Johnson VA Medical Center,
Charleston, South Carolina
The following contributors have declared all forms of support
received within the 12 months prior to manuscript submittal
that may represent a competing interest in relation to their
work published in this volume, as follows:
Kathleen T. Brady, M.D., Ph.D.—Consultant: Pfizer, Eli Lilly,
Abbott, GlaxoSmithKline, Forest Laboratories, Ovation;
Speaker's bureau: Pfizer, Eli Lilly, Abbott, GlaxoSmithKline, Forest Laboratories; Grant support: Abbott,
GlaxoSmithKline, Wyeth-Ayerst, Forest Laboratories.
Kathleen Carroll, Ph.D.—Member: Applied Behavioral Research,
LLC. This organization provides training and
develops training materials for a variety of empirically
supported therapies, including cognitive-behavioral
therapy.
Domenic A. Ciraulo, M.D.—Consultant: Alkermes; Clinical
trial contract: UCB Pharma.
Richard Frances, M.D.—Speaker: Cephalon, Alkermes, Forest
Laboratories; Stock: sanofi-aventis, Pfizer.
David R. Gastfriend, M.D.—Full-time employee of Alkermes,
Inc. and principal of RecoverySearch, Inc.
Tony P. George, M.D.—Grant support: National Institute on
Drug Abuse, National Institute of Health, NARSAD, Targacept,
Sepracor; Consultant: Pfizer, GlaxoSmithKline.
Herbert D. Kleber, M.D.—Consultant: Reckitt Benckiser.
Petros Levounis, M.D.—Speaker's bureau: AstraZeneca,
Forest, Cephalon, Takeda.
Hugh Myrick, M.D.—Grant support: Abbott, Forest, Bristol-Myers Squibb, Hythiam; Speaker: Abbott, Forest, Bristol-Myers Squibb, Cephalon.
Charles O'Brien, M.D., Ph.D.—Grant support: National Institute
on Drug Abuse, VA Medical Research Service; Consultant: Alkermes Corporation.
Kyle M. Kampman, M.D.—Grant support: National Institute
on Drug Abuse, VA Medical Research Service;
Speaker's bureau: Cephalon, Reckitt Benckiser.
Richard Rawson, Ph.D.—Consulting agreement with Catalyst
Pharmaceutical Partners to advise them on methamphetamine
treatment issues. They are considering
development of Vigabatrin.
Richard K. Ries, M.D.—Grant support: National Institute of
Health, SAMHSA/CSAT; Consultant/advisor/speaker's
bureau: Forest, Eli Lilly, Bristol-Myers Squibb, Pfizer,
Janssen, AstraZeneca.
Stephen Ross, M.D.—Speaker's bureau: Forest Pharmaceuticals,
Cephalon.
Eric Strain, M.D.—Consultant/travel support: Alkermes,
GlaxoSmithKline, Pinney Associates, Reckitt Benckiser,
Schering Plough, Shire, Titan, The Oak Group.
Andrea H. Weinberger, Ph.D.—Grant support: National Institute
on Drug Abuse, National Institute of Health, Sepracor.
Roger D. Weiss, M.D.—Board of advisors: Alkermes;
Speaker's bureau: Abbott.
The following contributors stated that they had no competing
interests during the year preceding manuscript submission:
Sudie E. Back, Ph.D.
Monica Barros, M.D.
Steven L. Batki, M.D.
Adam Bisaga, M.D.
J. Wesley Boyd, M.D., Ph.D.
David W. Brook, M.D.
Judith S. Brook, Ed.D.
Kirk J. Brower, M.D.
Robert Paul Cabaj, M.D.
Crystal A. Caudill, M.P.H.
Harvey L. Causey III, M.D.
Richard R. Clayton, Ph.D.
Wilson M. Compton, M.D., M.P.E.
Gerard J. Connors, Ph.D.
George De Leon, Ph.D.
Richard Denisco, M.D., M.P.H.
Daniel Dickerson, D.O., M.P.H.
Carlo C. DiClemente, Ph.D., A.B.P.P.
Robert L. DuPont, M.D.
Nady el-Guebaly, M.D.
William Fals-Stewart, Ph.D.
Loretta P. Finnegan, M.D.
Marc Galanter, M.D.
Miranda Garay, B.A.
Tracie J. Gardner, Ph.D.
Joel Gelernter, M.D.
Leigh Gemmell, Ph.D.
Richard A. Glennon, Ph.D.
Shelly F. Greenfield, M.D., M.P.H.
Eric W. Gunderson, M.D.
Margaret Haney, Ph.D.
Grace Hennessy, M.D.
Stephen T. Higgins, Ph.D.
Rocco A. Iannucci, M.D.
Yifrah Kaminer, M.D.
Stephen R. Kandall, M.D.
Clifford M. Knapp, Ph.D.
John R. Knight, M.D.
George F. Koob, Ph.D.
Thomas R. Kosten, M.D.
Henry R. Kranzler, M.D.
Mary Jeanne Kreek, M.D.
Frances R. Levin, M.D.
Walter Ling, M.D.
Michelle R. Lofwall, M.D.
Avram H. Mack, M.D.
A. Thomas McLellan, Ph.D.
David Mee-Lee, M.D.
Rudolf H. Moos, Ph.D.
Edgar P. Nace, M.D.
Kalpana I. Nathan, M.D.
Timothy J. O'Farrell, Ph.D.
Soteri Polydorou, M.D.
Harrison G. Pope Jr., M.D.
Jonathan I. Ritvo, M.D.
Jennifer Sharpe Potter, Ph.D., M.P.H.
Elizabeth Rubenstone, B.A.
Sidney H. Schnoll, M.D., Ph.D.
Richard S. Schottenfeld, M.D.
Melissa J.H. Segress, M.S.
Carl M. Selavka, Ph.D.
Kenneth Silverman, Ph.D.
Mehmet Sofuoglu, M.D., Ph.D.
Christine Timko, Ph.D.
J. Scott Tonigan, Ph.D.
Michael F. Weaver, M.D.
Joseph Westermeyer, M.D., Ph.D.
Tara Wright, M.D